Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
about
MDMA and the “Ecstasy Paradigm”3,4-methylenedioxymethamphetamine (MDMA): current perspectivesNeural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?Reasons for not using ecstasy: a qualitative study of non-users, ex-light users and ex-moderate users.Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents.Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats(+/-)3,4-Methylenedioxymethamphetamine (MDMA) dose-dependently impairs spatial learning in the morris water maze after exposure of rats to different five-day intervals from birth to postnatal day twenty.Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study.Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesMDMA effects consistent across laboratories.Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014).Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach.Clinical applications of hallucinogens: A review.The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.Understanding the Global Problem of Drug Addiction is a Challenge for IDARS ScientistsHeat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration.Effects of repeated 3,4-methylenedioxymethamphetamine administration on neurotransmitter efflux and sensory-evoked discharge in the ventral posterior medial thalamus.A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboonsEffects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.Maximising the highs and minimising the lows: harm reduction guidance within ecstasy distribution networks.Weekend Ecstasy use disrupts memory in rats.Molly users versus nonusers in a sample of college alcohol drinkers: Differences in substance-related harms and sensation seeking.Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes.Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the ratClinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
P2860
Q21558618-71250585-7E6D-465D-A1B9-0CA0B82B75A9Q24602762-B959C4B7-A2E0-4611-AEB5-9002DFD1A69BQ24619949-EB5FE6E1-A20A-48EC-B29F-50743255ACE5Q24627529-88847D02-671A-4B5E-9AFF-FF65EA914890Q30416744-7FC53996-B5D0-410B-8CC3-68EC41BD22EFQ30478967-81E5973C-72B8-4299-B74F-7E325782E7A5Q33390410-BDBF3FEC-C893-48C1-B675-9D9B5294690FQ33624591-66C753AD-23B0-4D83-BEAD-E8A77A4FD20AQ33624766-15D1EF1C-0E6F-4A47-9D04-BB337E9F148DQ33835470-F6B5A962-D01A-472F-8D1C-FA1F9D6643F5Q33923856-00258D08-CAE3-4C74-984C-F00C9382A441Q33940156-FAE71504-B897-4A6B-9F41-B241D08FBB03Q34030711-E1A79DA4-2C61-4041-AFED-BDAE95A30FACQ34112933-E0C81E65-4AB3-4113-97B2-63A23F5CE1E8Q34167689-040CC73C-2F2C-447D-ADDB-B01651166B5AQ34359604-9E44C135-60D3-46BE-9836-02B0E3F2EE70Q34407992-79698273-7229-4E60-AB15-B0A2AEB4DC17Q34460381-41AC3DD3-3221-4156-AF3B-2C014D7137E8Q34535259-2A5ABB83-8635-4884-B031-5301FDBFFBC9Q34786997-22345128-7C8D-4783-8B21-06B8387DB478Q35010538-6F599BFF-0FA4-46B8-A7C4-881AE115B0DAQ35107815-A47F4535-33B2-4B6F-A11B-8E7659012312Q35576531-B14EC1C5-5F03-4272-9307-7D1083CA9726Q35650765-6050E07A-191C-4CE4-A8B0-BCBF4CC49C62Q35851128-DF2BFB0F-5B6B-4EDA-98E6-4618A848E75BQ36123239-8955E048-A80E-42CE-8BF8-233BCAEB116BQ36410784-E767827E-3427-4FC8-9F3E-814A898BF5A8Q36666580-C12170F1-EE85-4830-98AC-4581BAF6F226Q36829594-47BE4F39-AC7D-479B-93FE-8AF7025A6F23Q36852604-8C94BCDD-FBC6-45BC-8F87-D3A79B27CC2DQ36875417-8FD25A20-1A95-413A-860F-D42138400A14Q37021831-88BBE084-ACCD-4AFA-9AE3-474FFB7F0E25Q37060354-B48A51A3-2FD2-4C81-A021-888CDC3FC727Q37194764-350B464E-F56B-47E5-81E1-AA8A878262D1Q37226589-4F33BE41-BB0F-4161-B311-E6D923DE8B77Q37323629-D88C8F0A-0310-4EA0-808E-F20D80EC6B31Q37351168-7F2B78F4-45C4-40FD-9D01-3EF4CF38B5D1Q37415781-D6B56A7C-A780-407D-B974-539645C53388Q37458263-A1D139BB-8F8B-4943-8688-C7727626854CQ37461894-1E2F31EB-BB0D-4821-981B-1F0C36A5666E
P2860
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
@ast
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
@en
type
label
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
@ast
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
@en
prefLabel
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
@ast
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
@en
P2860
P356
P1476
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
@en
P2093
Parrott AC
P2860
P356
10.1177/0269881105048900
P407
P577
2005-01-01T00:00:00Z